Montis Biosciences Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$7.7M
- Investors
-
6
Montis Biosciences General Information
Description
Developer of proprietary medical therapies designed to sustain immune reactions against solid tumors. The company's research therapeutically exploits cellular interactions between perivascular macrophages and tumor vasculature and provides insights into how these two classes of cells interact, enabling physicians to target various tumors from a different angle using novel therapeutic strategies.
Contact Information
Website
www.montisbio.comCorporate Office
- Arenberg Bio-Accelerator
- Gaston Geenslaan 3
- 3001 Leuven
- Belgium
Corporate Office
- Arenberg Bio-Accelerator
- Gaston Geenslaan 3
- 3001 Leuven
- Belgium
Montis Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 01-Apr-2022 | $7.7M | Completed | Pre-Clinical Trials | ||
| 2. Grant | 14-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 01-Mar-2021 | $4.23M | $4.23M | Completed | Pre-Clinical Trials |
Montis Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference Shares | ||||||||
| Preference Shares | ||||||||
| Preference Shares | 1,117,516 | $1.3 | $1.3 | 1x | $1.3 | 6.47% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Montis Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Montis Biosciences Patents
Montis Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026002904-A1 | C1q antigen binding molecules | Pending | 24-Jun-2024 | ||
| EP-4670793-A1 | C1q antigen-binding molecules | Pending | 24-Jun-2024 |
Montis Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Montis Biosciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| VLAIO | Limited Partner | |||
| ALSA Ventures | Venture Capital | Minority | ||
| Droia Ventures | Venture Capital | Minority | ||
| Pfizer Ventures | Corporate Venture Capital | Minority | ||
| Polaris Partners | Venture Capital | Minority |
Montis Biosciences FAQs
-
When was Montis Biosciences founded?
Montis Biosciences was founded in 2019.
-
Where is Montis Biosciences headquartered?
Montis Biosciences is headquartered in Leuven, Belgium.
-
What is the size of Montis Biosciences?
Montis Biosciences has 14 total employees.
-
What industry is Montis Biosciences in?
Montis Biosciences’s primary industry is Drug Discovery.
-
Is Montis Biosciences a private or public company?
Montis Biosciences is a Private company.
-
What is the current valuation of Montis Biosciences?
The current valuation of Montis Biosciences is .
-
What is Montis Biosciences’s current revenue?
The current revenue for Montis Biosciences is .
-
How much funding has Montis Biosciences raised over time?
Montis Biosciences has raised $11.9M.
-
Who are Montis Biosciences’s investors?
VLAIO, ALSA Ventures, Droia Ventures, Pfizer Ventures, and Polaris Partners are 5 of 6 investors who have invested in Montis Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
